Advicenne
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or co… Read more
Advicenne (ALDVI) - Total Assets
Latest total assets as of June 2025: €6.73 Million EUR
Based on the latest financial reports, Advicenne (ALDVI) holds total assets worth €6.73 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Advicenne - Total Assets Trend (2014–2024)
This chart illustrates how Advicenne’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Advicenne - Asset Composition Analysis
Current Asset Composition (December 2024)
Advicenne's total assets of €6.73 Million consist of 92.6% current assets and 7.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €3.25 Million | 34.2% |
| Accounts Receivable | €3.73 Million | 39.3% |
| Inventory | €1.68 Million | 17.7% |
| Property, Plant & Equipment | €225.93K | 2.4% |
| Intangible Assets | €302.00K | 3.2% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Advicenne's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Advicenne's current assets represent 92.6% of total assets in 2024, an increase from 91.0% in 2014.
- Cash Position: Cash and equivalents constituted 34.2% of total assets in 2024, down from 46.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 39.3% of total assets.
Advicenne Competitors by Total Assets
Key competitors of Advicenne based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Advicenne - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Advicenne generates 0.52x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Advicenne is currently not profitable relative to its asset base.
Advicenne - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.36 | 3.42 |
| Quick Ratio | 0.45 | 0.26 | 3.34 |
| Cash Ratio | 0.05 | 0.11 | 2.74 |
| Working Capital | €-4.24 Million | € -11.69 Million | € 15.79 Million |
Advicenne - Advanced Valuation Insights
This section examines the relationship between Advicenne's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 127.70 |
| Latest Market Cap to Assets Ratio | 1.67 |
| Asset Growth Rate (YoY) | -23.4% |
| Total Assets | €9.51 Million |
| Market Capitalization | $15.84 Million USD |
Valuation Analysis
Above Book Valuation: The market values Advicenne's assets above their book value (1.67 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Advicenne's assets decreased by 23.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Advicenne (2014–2024)
The table below shows the annual total assets of Advicenne from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €9.51 Million | -23.37% |
| 2023-12-31 | €12.41 Million | -12.99% |
| 2022-12-31 | €14.26 Million | -24.48% |
| 2021-12-31 | €18.88 Million | -21.34% |
| 2020-12-31 | €24.00 Million | +4.73% |
| 2019-12-31 | €22.92 Million | -30.91% |
| 2018-12-31 | €33.17 Million | -14.09% |
| 2017-12-31 | €38.62 Million | +1086.02% |
| 2016-12-31 | €3.26 Million | +9.26% |
| 2015-12-31 | €2.98 Million | -7.51% |
| 2014-12-31 | €3.22 Million | -- |